HeartSciences

HeartSciences is a medical technology company focused on applying artificial intelligence (AI) and advanced signal processing to electrocardiography (ECG/EKG) to improve the early detection of heart disease. The company's core technology, the MyoVista wavECG, utilizes continuous wavelet transform (CWT) signal processing to detect cardiac dysfunction related to impaired relaxation, a key early indicator of heart disease that conventional ECGs often miss. In addition to its hardware, HeartSciences has developed MyoVista Insights, a cloud-native, hardware-agnostic platform designed to host a library of AI-ECG algorithms. Through a major partnership with the Icahn School of Medicine at Mount Sinai, the company has gained access to a vast repository of ECG data and algorithms, positioning itself as a leader in the emerging AI-ECG diagnostic market. The company aims to bridge the diagnostic gap between low-cost frontline ECG testing and expensive cardiac imaging.